Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
We report the first case, to our knowledge, of Blastoschizomyces capitatus infection occurring in a patient receiving empirical echinocandin therapy for neutropenic fevers. Clinicians should consider B. capitatus infection in those neutropenic patients who remain febrile despite echinocandin therapy or who develop yeast bloodstream infections while receiving an echinocandin.
Chittick
Paul
P
Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Palavecino
Elizabeth L
EL
Delashmitt
Brian
B
Evans
James
J
Peacock
James E
JE
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D054714:Echinocandins / Q000627:therapeutic use*; D017809:Fatal Outcome; D005847:Geotrichosis / Q000150:complications* / Q000382:microbiology; D005848:Geotrichum / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D055666:Lipopeptides / Q000627:therapeutic use*; D008297:Male; D000077551:Micafungin; D008826:Microbial Sensitivity Tests; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077551:Micafungin